生命科学资讯

Kura says its menin inhibitor is preferred treatment for some payers

Roche partner Zealand posts Phase 2 data for amylin obesity drug

Roche, Element and Ultima push toward the $100 genome

FDA approves J&J's multiple myeloma combo as second-line treatment

Helus Pharma's stock slides after psychedelic drug data face questions over dosing

New FDA bonus pilot to address 'workforce challenges'

Eli Lilly's new program aims to boost employer coverage of GLP-1s

Tenaya wins support from Alnylam in cardio disease pact

Health AI dispatch from SF

China is taking on the world’s 10 most expensive medicines

Merck KGaA drops two cancer trials on assets from SpringWorks deal

Novo Nordisk details Irish expansion; EuroAPI’s challenges continue

How hospitals have shifted from experimenting with AI to justifying its cost

Yale’s Craig Crews builds model to guide biotech startups out of academia’s ‘valley of death’

FDA's top operating official Butler to retire, deputy to take over in April

Bayer continues trimming workforce; AnaptysBio's spinoff is named

BIO chief still backs FDA's Makary despite 'head-scratcher' decisions

Sanofi licenses Sino Biopharm’s transplant drug for $135M upfront

UCB boards T cell engager train in $60M upfront deal with Antengene